Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
15.71 USD 5.36 ( 51.79%)
Last update at 2026-11-06T21:03:00Z
VOLUME
432790
Market Cap
87.85M

Momentum Score

…

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
11.52
Low
15.95
High
52 Week Price Range
0.55
Low
2.56
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
10.35
Dividend Yield
-
Revenue TTM
290.05M
Revenue Per Share
2.27
Gross Profit TTM
192.45M
Debt / Equity
6.20
ROE
-43.89%
Net Debt
146.00M
ROCE
4.27%
Diluted EPS TTM
-0.22

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -5.94M -29.55M -101.89M 45.03M -377.35M
Net income -9.52M -29.10M -100.12M 44.38M -375.11M
Selling general administrative 117.95M 125.46M 131.43M 106.10M 98.69M
Selling and marketing expenses 93.59M 118.31M 144.50M 160.08M 111.58M
Gross profit 196.36M 182.30M 155.11M 250.34M 181.83M
Reconciled depreciation 25.35M 33.68M 28.64M 22.02M 21.28M
Ebit 13.39M -19.14M -88.24M -24.28M -36.64M
Ebitda 38.74M 10.34M -53.56M -16.75M -88.19M
Depreciation and amortization 25.35M 29.48M 34.67M 7.53M -51.55M
Non operating income net other - - - 82.70M -328.93M
Operating income -20.80M -67.77M -130.92M -24.28M -36.64M
Other operating expenses 321.59M 402.07M 528.91M 390.16M 296.73M
Interest expense 19.33M 10.41M 13.65M 13.39M 11.78M
Tax provision 3.58M -0.45M -3.60M 0.65M -2.24M
Interest income 8.95M 16.64M 23.17M 9.18M -
Net interest income -10.37M 6.23M 9.52M -4.22M -11.78M
Income tax expense 3.58M -0.45M -1.77M 0.65M -2.24M
Total revenue 300.79M 334.29M 397.99M 365.88M 260.09M
Total operating expenses 217.17M 250.07M 286.03M 274.62M 218.47M
Cost of revenue 104.43M 152.00M 242.88M 115.54M 78.26M
Total other income expense net 14.87M 38.22M 29.03M 69.31M -340.71M
Net income from continuing ops -9.52M -29.10M -100.12M 44.38M -375.11M
Net income applicable to common shares - - - 44.38M -375.11M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 499.80M 685.68M 929.11M 1008.91M 1218.81M
Intangible assets 35.80M 47.51M 62.12M 46.39M 56.01M
Other current assets 5.36M 9.49M 13.88M 26.70M 12.32M
Total liab 438.70M 633.88M 869.72M 837.43M 916.51M
Total stockholder equity 61.10M 51.80M 59.39M 171.48M 302.30M
Deferred long term liab - - - 2.01M 3.56M
Other current liab 40.41M 19.31M 62.88M 37.01M 3.71M
Common stock 0.01M 0.01M 0.01M 0.01M 0.02M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.02M
Retained earnings -517.50M -507.96M -478.87M -374.33M -418.71M
Other liab - - - 17.48M 97.38M
Good will 126.60M 123.50M 125.82M 124.59M 123.69M
Other assets - - - 15.01M 7.04M
Cash 232.70M 370.06M 523.02M 568.20M 901.89M
Total current liabilities 186.30M 68.15M 115.01M 73.11M 76.44M
Current deferred revenue - 2.38M 2.76M 0.81M 39.96M
Net debt 146.00M 198.09M 229.26M 183.59M -171.97M
Short term debt 129.09M 5.15M 4.60M 4.96M 3.71M
Short long term debt 123.96M - - - -
Short long term debt total 378.70M 568.16M 752.29M 751.79M 729.91M
Other stockholder equity 579.96M 566.71M 541.28M 550.32M 722.25M
Property plant equipment - - - 33.82M 31.18M
Total current assets 309.50M 477.12M 698.25M 789.10M 1000.89M
Net tangible assets - - - 0.50M 122.59M
Net receivables 23.44M 28.46M 70.03M 77.77M 51.42M
Long term debt 240.43M 552.20M 738.37M 734.14M 729.91M
Inventory 48.00M 69.11M 91.32M 116.43M 35.26M
Accounts payable 15.60M 21.94M 44.77M 30.34M 29.05M
Accumulated other comprehensive income -1.40M -6.95M -3.04M -4.53M -1.26M
Common stock total equity - - - 0.01M 0.02M
Retained earnings total equity - - - -374.33M -418.71M
Non currrent assets other 11.90M 14.09M 16.04M 14.19M 6.71M
Non current assets total 190.30M 208.56M 230.86M 219.81M 217.91M
Capital lease obligations 14.37M 15.96M 13.92M 17.65M 16.49M
Long term debt total - - - 734.14M 729.91M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -6.79M -31.51M -18.87M 0.78M
Change to liabilities - - - -1.55M 34.71M
Total cashflows from investing activities -5.16M -6.79M -31.51M -18.87M -37.73M
Net borrowings -173.35M -156.08M 0.00M - 413.02M
Total cash from financing activities -174.93M -158.34M -37.45M -205.24M 959.03M
Change to operating activities - - - -31.84M 11.83M
Net income -9.52M -29.10M -100.12M 44.38M -375.11M
Change in cash -137.39M -152.96M -45.17M -333.69M 892.40M
Begin period cash flow 370.06M 523.02M 568.20M 901.89M 9.49M
End period cash flow 232.67M 370.06M 523.02M 568.20M 901.89M
Total cash from operating activities 37.48M 16.13M 21.75M -106.60M -28.36M
Depreciation 25.35M 33.68M 34.67M 22.02M 21.14M
Other cashflows from investing activities -4.86M -6.79M -18.46M -8.02M -27.31M
Change to inventory 15.79M -10.50M -22.62M -82.10M -9.44M
Change to account receivables 5.16M 20.80M 16.52M -32.02M -31.01M
Sale purchase of stock 0.00M -1.96M -32.40M -160.00M 188.38M
Other cashflows from financing activities -1.57M -0.30M -5.05M -45.74M 1189.52M
Change to netincome - - - -42.36M 292.97M
Capital expenditures 5.16M 6.79M 13.05M 17.39M 15.62M
Change receivables - - - -32.02M -31.01M
Cash flows other operating - - - -15.82M 41.59M
Cash and cash equivalents changes - - - -330.71M 892.94M
Change in working capital 10.37M -27.39M 23.36M -140.28M -18.66M
Stock based compensation 14.82M 26.70M 22.54M 28.50M 12.42M
Other non cash items -5.76M 16.00M 42.37M -59.42M 335.62M
Free cash flow 32.32M 9.34M 8.70M -123.99M -43.98M

Peer Comparison*

Sector: Consumer Defensive Industry: Household & Personal Products

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SKIN
SkinHealth Systems Inc.
5.36
51.79%
15.71 - 106.38 0.30 1.64 0.87 9.70
PG
Procter & Gamble Company
-1.70
1.02%
165.40 23.58 22.62 4.07 7.24 4.40 16.08
LRLCF
L'Oréal S.A
-25.50
5.05%
479.50 41.14 34.25 6.52 8.59 6.67 27.76
LRLCY
L’Oreal Co ADR
-1.19
1.17%
100.37 32.44 25.64 5.16 6.03 4.79 19.51
UL
Unilever PLC ADR
-1.71
2.53%
66.00 21.53 16.39 2.66 7.29 2.77 12.45

Profile*

SkinHealth Systems Inc.

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

3600 E. Burnett Street, Long Beach, CA, United States, 90815

800 603 4996

613

Name Title Year Born
Mr. Brenton L. Saunders J.D. Exec. Chairman 1970
Ms. Liyuan Woo Chief Financial Officer 1972
Mr. Daniel Copell Watson Exec. VP of Americas Sales 1962
Mr. Andrew Stanleick Pres, CEO & Director 1971
Eduardo Rodriguez Sr. Director of M&A and Investor Relations NA
Mr. Paul Bokota VP & Gen. Counsel NA
Ms. Kellie Sears Chief HR Officer NA
Dr. Jwala Karnik M.D. Exec. VP of Strategy & Partnership NA
Mr. Benjamin C. Baum Chief Experience Officer 1973
Mr. Mingo Ku Pres of North Asia NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…